{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T07:02:19Z","timestamp":1743145339638,"version":"3.40.3"},"publisher-location":"Cham","reference-count":100,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031619380"},{"type":"electronic","value":"9783031619397"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-61939-7_6","type":"book-chapter","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:02:29Z","timestamp":1726484549000},"page":"111-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathophysiology of COVID\u201019\u2010Related Extrapyramidal Disorders"],"prefix":"10.1007","author":[{"given":"Francesco","family":"Cavallieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialuisa","family":"Zedde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Moratti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Pascarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Valzania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cytogfr.2021.11.001","volume":"63","author":"MS Alam","year":"2022","unstructured":"Alam MS, Czajkowsky DM (2022) SARS-CoV-2 infection and oxidative stress: pathophysiological insight into thrombosis and therapeutic opportunities. Cytokine Growth Factor Rev 63:44\u201357. https:\/\/doi.org\/10.1016\/j.cytogfr.2021.11.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"6_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01831-0","author":"EA Albornoz","year":"2022","unstructured":"Albornoz EA, Amarilla AA, Modhiran N et al (2022) SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-022-01831-0","journal-title":"Mol Psychiatry"},{"key":"6_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.670298","volume":"15","author":"IO Awogbindin","year":"2021","unstructured":"Awogbindin IO, Ben-Azu B, Olusola BA et al (2021) Microglial Implications in SARS-CoV-2 Infection and COVID-19: lessons from viral RNA neurotropism and possible relevance to Parkinson\u2019s disease. Front Cell Neurosci 15:670298. https:\/\/doi.org\/10.3389\/fncel.2021.670298","journal-title":"Front Cell Neurosci"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3233\/JPD-202211","volume":"10","author":"LC Beauchamp","year":"2020","unstructured":"Beauchamp LC, Finkelstein DI, Bush AI et al (2020) Parkinsonism as a third wave of the COVID-19 pandemic? J Parkinsons Dis 10:1343\u20131353. https:\/\/doi.org\/10.3233\/JPD-202211","journal-title":"J Parkinsons Dis"},{"key":"6_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111573","volume":"41","author":"D Beckman","year":"2022","unstructured":"Beckman D, Bonillas A, Diniz GB et al (2022) SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19. Cell Rep 41:111573. https:\/\/doi.org\/10.1016\/j.celrep.2022.111573","journal-title":"Cell Rep"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1111\/ene.14652","volume":"28","author":"E Beghi","year":"2021","unstructured":"Beghi E, Helbok R, Crean M et al (2021) The European Academy of Neurology COVID-19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID-19. Eur J Neurol 28:3303\u20133323. https:\/\/doi.org\/10.1111\/ene.14652","journal-title":"Eur J Neurol"},{"key":"6_CR7","doi-asserted-by":"publisher","unstructured":"Beghi E, Moro E, Davidescu EI et al (2023) Comparative features and outcomes of major neurological complications of COVID-19. Euro J Neurol 30:413\u2013433. https:\/\/doi.org\/10.1111\/ene.15617","DOI":"10.1111\/ene.15617"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/JPD-160921","volume":"7","author":"E Bentea","year":"2017","unstructured":"Bentea E, Verbruggen L, Massie A (2017) The Proteasome inhibition model of Parkinson\u2019s disease. J Parkinsons Dis 7:31\u201363. https:\/\/doi.org\/10.3233\/JPD-160921","journal-title":"J Parkinsons Dis"},{"key":"6_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-022-04593-z","author":"C Bhowal","year":"2022","unstructured":"Bhowal C, Ghosh S, Ghatak D, De R (2022) Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-022-04593-z","journal-title":"Mol Cell Biochem"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1007\/s00415-021-10444-6","volume":"268","author":"VA Blanco-Palmero","year":"2021","unstructured":"Blanco-Palmero VA, Azc\u00e1rate-D\u00edaz FJ, Ruiz-Ortiz M et al (2021) Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms. J Neurol 268:3116\u20133124. https:\/\/doi.org\/10.1007\/s00415-021-10444-6","journal-title":"J Neurol"},{"key":"6_CR11","doi-asserted-by":"publisher","unstructured":"Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson\u2019s disease. Front Neuroanat 9. https:\/\/doi.org\/10.3389\/fnana.2015.00091","DOI":"10.3389\/fnana.2015.00091"},{"key":"6_CR12","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000923","volume":"8","author":"M Bodro","year":"2021","unstructured":"Bodro M, Compta Y, S\u00e1nchez-Valle R (2021) Presentations and mechanisms of CNS disorders related to COVID-19. Neurol Neuroimmunol Neuroinflamm 8:e923. https:\/\/doi.org\/10.1212\/NXI.0000000000000923","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fncel.2018.00386","volume":"12","author":"K Bohmwald","year":"2018","unstructured":"Bohmwald K, G\u00e1lvez NMS, R\u00edos M, Kalergis AM (2018) Neurologic alterations due to respiratory virus infections. Front Cell Neurosci 12:386. https:\/\/doi.org\/10.3389\/fncel.2018.00386","journal-title":"Front Cell Neurosci"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-201981","volume":"11","author":"M Borsche","year":"2021","unstructured":"Borsche M, Pereira SL, Klein C, Gr\u00fcnewald A (2021) Mitochondria and Parkinson\u2019s disease: clinical, molecular, and translational aspects. J Parkinsons Dis 11:45\u201360. https:\/\/doi.org\/10.3233\/JPD-201981","journal-title":"J Parkinsons Dis"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1002\/mds.28680","volume":"36","author":"R Bouali-Benazzouz","year":"2021","unstructured":"Bouali-Benazzouz R, Benazzouz A (2021) Covid-19 infection and Parkinsonism: is there a link? Mov Disord 36:1737\u20131743. https:\/\/doi.org\/10.1002\/mds.28680","journal-title":"Mov Disord"},{"key":"6_CR16","doi-asserted-by":"publisher","unstructured":"Burtscher J, Cappellano G, Omori A et al (2020) Mitochondria: in the cross fire of SARS-CoV-2 and immunity. iScience 23:101631. https:\/\/doi.org\/10.1016\/j.isci.2020.101631","DOI":"10.1016\/j.isci.2020.101631"},{"key":"6_CR17","doi-asserted-by":"publisher","unstructured":"Calculli A, Bocci T, Porcino M et al (2023) Parkinson disease following COVID\u201019: report of six cases. Euro J Neurol 15732. https:\/\/doi.org\/10.1111\/ene.15732","DOI":"10.1111\/ene.15732"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3390\/cells12050764","volume":"12","author":"F Cavallieri","year":"2023","unstructured":"Cavallieri F, Cury RG, Guimar\u00e3es T et al (2023) Recent advances in the treatment of genetic forms of Parkinson\u2019s disease: hype or hope? Cells 12:764. https:\/\/doi.org\/10.3390\/cells12050764","journal-title":"Cells"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/biom12070970","volume":"12","author":"F Cavallieri","year":"2022","unstructured":"Cavallieri F, Fioravanti V, Bove F et al (2022a) COVID-19 and parkinsonism: a critical appraisal. Biomolecules 12:970. https:\/\/doi.org\/10.3390\/biom12070970","journal-title":"Biomolecules"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00415-021-10694-4","volume":"269","author":"F Cavallieri","year":"2022","unstructured":"Cavallieri F, Fioravanti V, Toschi G et al (2022b) COVID-19 and Parkinson\u2019s disease: a casual association or a possible second hit in neurodegeneration? J Neurol 269:59\u201361. https:\/\/doi.org\/10.1007\/s00415-021-10694-4","journal-title":"J Neurol"},{"key":"6_CR21","doi-asserted-by":"crossref","unstructured":"Cavallieri F, Sellner J, Zedde M, Moro E (2022c) Neurologic complications of coronavirus and other respiratory viral infections. In: Handbook of clinical neurology. Elsevier, Amsterdam, pp 331\u2013358","DOI":"10.1016\/B978-0-323-91532-8.00004-5"},{"key":"6_CR22","doi-asserted-by":"publisher","unstructured":"Cevik M, Kuppalli K, Kindrachuk J, Peiris M (2020) Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ m3862. https:\/\/doi.org\/10.1136\/bmj.m3862","DOI":"10.1136\/bmj.m3862"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3389\/fneur.2020.01044","volume":"11","author":"P Chan\u00e1-Cuevas","year":"2020","unstructured":"Chan\u00e1-Cuevas P, Salles-G\u00e1ndara P, Rojas-Fernandez A et al (2020) The potential role of SARS-COV-2 in the pathogenesis of Parkinson\u2019s disease. Front Neurol 11:1044. https:\/\/doi.org\/10.3389\/fneur.2020.01044","journal-title":"Front Neurol"},{"key":"6_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.573095","volume":"11","author":"R Chen","year":"2021","unstructured":"Chen R, Wang K, Yu J et al (2021) The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol 11:573095. https:\/\/doi.org\/10.3389\/fneur.2020.573095","journal-title":"Front Neurol"},{"key":"6_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.12131","volume":"4","author":"SH-Y Chou","year":"2021","unstructured":"Chou SH-Y, Beghi E, Helbok R et al (2021) Global incidence of neurological manifestations among patients hospitalized with COVID-19\u2014a report for the GCS-NeuroCOVID consortium and the energy consortium. JAMA Netw Open 4:e2112131. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.12131","journal-title":"JAMA Netw Open"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S1474-4422(20)30305-7","volume":"19","author":"ME Cohen","year":"2020","unstructured":"Cohen ME, Eichel R, Steiner-Birmanns B et al (2020) A case of probable Parkinson\u2019s disease after SARS-CoV-2 infection. Lancet Neurol 19:804\u2013805. https:\/\/doi.org\/10.1016\/S1474-4422(20)30305-7","journal-title":"Lancet Neurol"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1111\/ene.15045","volume":"28","author":"G Cosentino","year":"2021","unstructured":"Cosentino G, Todisco M, Hota N et al (2021) Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review. Euro J Neurol 28:3856\u20133865. https:\/\/doi.org\/10.1111\/ene.15045","journal-title":"Euro J Neurol"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s10072-020-04964-8","volume":"42","author":"I Desai","year":"2021","unstructured":"Desai I, Manchanda R, Kumar N et al (2021) Neurological manifestations of coronavirus disease 2019: exploring past to understand present. Neurol Sci 42:773\u2013785. https:\/\/doi.org\/10.1007\/s10072-020-04964-8","journal-title":"Neurol Sci"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The Role of Oxidative stress in Parkinson\u2019s disease. J Parkinson\u2019s Dis 3:461\u2013491. https:\/\/doi.org\/10.3233\/JPD-130230","journal-title":"J Parkinson\u2019s Dis"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/cells8010004","volume":"8","author":"Z Dong","year":"2018","unstructured":"Dong Z, Cui H (2018) The autophagy-lysosomal pathways and their emerging roles in modulating proteostasis in tumors. Cells 8:4. https:\/\/doi.org\/10.3390\/cells8010004","journal-title":"Cells"},{"key":"6_CR31","doi-asserted-by":"publisher","unstructured":"Emmi A, Rizzo S, Barzon L et al (2023) Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei. NPJ Parkinsons Dis 9:25. https:\/\/doi.org\/10.1038\/s41531-023-00467-3","DOI":"10.1038\/s41531-023-00467-3"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/mds.28656","volume":"36","author":"C Fearon","year":"2021","unstructured":"Fearon C, Mikulis DJ, Lang AE (2021) Parkinsonism as a sequela of SARS-CoV-2 infection: pure hypoxic injury or additional COVID-19-related response? Mov Disord 36:1483\u20131484. https:\/\/doi.org\/10.1002\/mds.28656","journal-title":"Mov Disord"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"1111930","DOI":"10.3389\/fmicb.2022.1111930","volume":"13","author":"C Gain","year":"2023","unstructured":"Gain C, Song S, Angtuaco T et al (2023) The role of oxidative stress in the pathogenesis of infections with coronaviruses. Front Microbiol 13:1111930. https:\/\/doi.org\/10.3389\/fmicb.2022.1111930","journal-title":"Front Microbiol"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.cell.2020.10.039","volume":"183","author":"S Ghosh","year":"2020","unstructured":"Ghosh S, Dellibovi-Ragheb TA, Kerviel A et al (2020) \u03b2-Coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway. Cell 183:1520-1535.e14. https:\/\/doi.org\/10.1016\/j.cell.2020.10.039","journal-title":"Cell"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/biomedicines10020371","volume":"10","author":"NA Gouda","year":"2022","unstructured":"Gouda NA, Elkamhawy A, Cho J (2022) Emerging therapeutic strategies for Parkinson\u2019s disease and future prospects: a 2021 Update. Biomedicines 10:371. https:\/\/doi.org\/10.3390\/biomedicines10020371","journal-title":"Biomedicines"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis M et al (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631\u2013637. https:\/\/doi.org\/10.1002\/path.1570","journal-title":"J Pathol"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H (2007) Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33:599\u2013614. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00874.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271-280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cell.2020.08.028","volume":"183","author":"C Iadecola","year":"2020","unstructured":"Iadecola C, Anrather J, Kamel H (2020) Effects of COVID-19 on the nervous system. Cell 183:16-27.e1. https:\/\/doi.org\/10.1016\/j.cell.2020.08.028","journal-title":"Cell"},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbrc.2021.03.100","volume":"554","author":"D Idrees","year":"2021","unstructured":"Idrees D, Kumar V (2021) SARS-CoV-2 spike protein interactions with amyloidogenic proteins: potential clues to neurodegeneration. Biochem Biophys Res Commun 554:94\u201398. https:\/\/doi.org\/10.1016\/j.bbrc.2021.03.100","journal-title":"Biochem Biophys Res Commun"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson CB, Farzan M, Chen B, Choe H (2022) Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 23:3\u201320. https:\/\/doi.org\/10.1038\/s41580-021-00418-x","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6_CR42","doi-asserted-by":"publisher","unstructured":"K\u00e4ufer C, Schreiber CS, Hartke A-S et al (2022) Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. eBioMedicine 79:103999. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103999","DOI":"10.1016\/j.ebiom.2022.103999"},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/1073858420941476","volume":"26","author":"D Kempuraj","year":"2020","unstructured":"Kempuraj D, Selvakumar GP, Ahmed ME et al (2020) COVID-19, Mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist 26:402\u2013414. https:\/\/doi.org\/10.1177\/1073858420941476","journal-title":"Neuroscientist"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12575-021-00145-9","volume":"23","author":"F Khomari","year":"2021","unstructured":"Khomari F, Nabi-Afjadi M, Yarahmadi S et al (2021) Effects of cell proteostasis network on the survival of SARS-CoV-2. Biol Proced Online 23:8. https:\/\/doi.org\/10.1186\/s12575-021-00145-9","journal-title":"Biol Proced Online"},{"key":"6_CR45","doi-asserted-by":"publisher","first-page":"E105","DOI":"10.1152\/ajpendo.00198.2020","volume":"319","author":"E Korakas","year":"2020","unstructured":"Korakas E, Ikonomidis I, Kousathana F et al (2020) Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metabol 319:E105\u2013E109. https:\/\/doi.org\/10.1152\/ajpendo.00198.2020","journal-title":"Am J Physiol Endocrinol Metabol"},{"key":"6_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101816","volume":"84","author":"A Kulkarni","year":"2023","unstructured":"Kulkarni A, Preeti K, Tryphena KP et al (2023) Proteostasis in Parkinson\u2019s disease: recent development and possible implication in diagnosis and therapeutics. Ageing Res Rev 84:101816. https:\/\/doi.org\/10.1016\/j.arr.2022.101816","journal-title":"Ageing Res Rev"},{"key":"6_CR47","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev-biochem-060614-033955","volume":"84","author":"J Labbadia","year":"2015","unstructured":"Labbadia J, Morimoto RI (2015) The biology of proteostasis in aging and disease. Annu Rev Biochem 84:435\u2013464. https:\/\/doi.org\/10.1146\/annurev-biochem-060614-033955","journal-title":"Annu Rev Biochem"},{"key":"6_CR48","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.3390\/ijms23116188","volume":"23","author":"Y Lan","year":"2022","unstructured":"Lan Y, He W, Wang G et al (2022) Potential Antiviral Strategy exploiting dependence of SARS-CoV-2 replication on lysosome-based pathway. Int J Mol Sci 23:6188. https:\/\/doi.org\/10.3390\/ijms23116188","journal-title":"Int J Mol Sci"},{"key":"6_CR49","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fcell.2019.00170","volume":"7","author":"C Li","year":"2019","unstructured":"Li C, Wang X, Li X et al (2019) Proteasome inhibition activates autophagy-lysosome pathway associated with TFEB dephosphorylation and nuclear translocation. Front Cell Dev Biol 7:170. https:\/\/doi.org\/10.3389\/fcell.2019.00170","journal-title":"Front Cell Dev Biol"},{"issue":"Suppl1","key":"6_CR50","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1186\/1471-2091-8-S1-S13","volume":"8","author":"K-L Lim","year":"2007","unstructured":"Lim K-L, Tan JMM (2007) Role of the ubiquitin proteasome system in Parkinson\u2019s disease. BMC Biochem 8(Suppl1):S13. https:\/\/doi.org\/10.1186\/1471-2091-8-S1-S13","journal-title":"BMC Biochem"},{"key":"6_CR51","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/22221751.2021.2024095","volume":"11","author":"K-S Lyoo","year":"2022","unstructured":"Lyoo K-S, Kim HM, Lee B et al (2022) Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients. Emerg Microbes Infect 11:407\u2013412. https:\/\/doi.org\/10.1080\/22221751.2021.2024095","journal-title":"Emerg Microbes Infect"},{"key":"6_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117331","volume":"422","author":"K Makhoul","year":"2021","unstructured":"Makhoul K, Jankovic J (2021) Parkinson\u2019s disease after COVID-19. J Neurol Sci 422:117331. https:\/\/doi.org\/10.1016\/j.jns.2021.117331","journal-title":"J Neurol Sci"},{"key":"6_CR53","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011119","volume":"97","author":"J Mandrioli","year":"2018","unstructured":"Mandrioli J, D\u2019Amico R, Zucchi E et al (2018) Rapamycin treatment for amyotrophic lateral sclerosis: protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial). Medicine 97:e11119. https:\/\/doi.org\/10.1097\/MD.0000000000011119","journal-title":"Medicine"},{"key":"6_CR54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/embj.201385902","volume":"33","author":"G-L McLelland","year":"2014","unstructured":"McLelland G-L, Soubannier V, Chen CX et al (2014) Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J 33:282\u2013295. https:\/\/doi.org\/10.1002\/embj.201385902","journal-title":"EMBO J"},{"key":"6_CR55","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"6_CR56","doi-asserted-by":"publisher","first-page":"e2109","DOI":"10.1212\/WNL.0000000000010282","volume":"95","author":"A M\u00e9ndez-Guerrero","year":"2020","unstructured":"M\u00e9ndez-Guerrero A, Laespada-Garc\u00eda MI, G\u00f3mez-Grande A et al (2020) Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology 95:e2109\u2013e2118. https:\/\/doi.org\/10.1212\/WNL.0000000000010282","journal-title":"Neurology"},{"key":"6_CR57","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(20)30442-7","volume":"20","author":"M Merello","year":"2021","unstructured":"Merello M, Bhatia KP, Obeso JA (2021) SARS-CoV-2 and the risk of Parkinson\u2019s disease: facts and fantasy. Lancet Neurol 20:94\u201395. https:\/\/doi.org\/10.1016\/S1474-4422(20)30442-7","journal-title":"Lancet Neurol"},{"key":"6_CR58","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1111\/ene.14407","volume":"27","author":"E Moro","year":"2020","unstructured":"Moro E, Priori A, Beghi E et al (2020) The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection. Eur J Neurol 27:1727\u20131737. https:\/\/doi.org\/10.1111\/ene.14407","journal-title":"Eur J Neurol"},{"key":"6_CR59","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1089\/ars.2010.3799","volume":"14","author":"DP Narendra","year":"2011","unstructured":"Narendra DP, Youle RJ (2011) Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control. Antioxid Redox Signal 14:1929\u20131938. https:\/\/doi.org\/10.1089\/ars.2010.3799","journal-title":"Antioxid Redox Signal"},{"key":"6_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10286-019-00662-4","volume":"30","author":"A Ndayisaba","year":"2020","unstructured":"Ndayisaba A, Wenning GK (2020) Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy. Clin Auton Res 30:7\u20138. https:\/\/doi.org\/10.1007\/s10286-019-00662-4","journal-title":"Clin Auton Res"},{"key":"6_CR61","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bbadis.2008.10.002","volume":"1782","author":"NB Nedelsky","year":"2008","unstructured":"Nedelsky NB, Todd PK, Taylor JP (2008) Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection. Biochim Biophys Acta 1782:691\u2013699. https:\/\/doi.org\/10.1016\/j.bbadis.2008.10.002","journal-title":"Biochim Biophys Acta"},{"key":"6_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.rceng.2020.03.001","volume":"221","author":"M Palacios Cruz","year":"2021","unstructured":"Palacios Cruz M, Santos E, Vel\u00e1zquez Cervantes MA, Le\u00f3n Ju\u00e1rez M (2021) COVID-19, a worldwide public health emergency. Revista Cl\u00ednica Espa\u00f1ola (English Edition) 221:55\u201361. https:\/\/doi.org\/10.1016\/j.rceng.2020.03.001","journal-title":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)"},{"key":"6_CR63","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.arcmed.2021.03.010","volume":"52","author":"A Pavli","year":"2021","unstructured":"Pavli A, Theodoridou M, Maltezou HC (2021) Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res 52:575\u2013581. https:\/\/doi.org\/10.1016\/j.arcmed.2021.03.010","journal-title":"Arch Med Res"},{"key":"6_CR64","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/v14040776","volume":"14","author":"IHCHM Philippens","year":"2022","unstructured":"Philippens IHCHM, B\u00f6sz\u00f6rm\u00e9nyi KP, Wubben JAM et al (2022) Brain inflammation and intracellular \u03b1-Synuclein aggregates in macaques after SARS-CoV-2 infection. Viruses 14:776. https:\/\/doi.org\/10.3390\/v14040776","journal-title":"Viruses"},{"key":"6_CR65","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/NNR.0000000000000565","volume":"71","author":"JD Pierce","year":"2022","unstructured":"Pierce JD, Shen Q, Cintron SA, Hiebert JB (2022) Post-COVID-19 syndrome. Nurs Res 71:164\u2013174. https:\/\/doi.org\/10.1097\/NNR.0000000000000565","journal-title":"Nurs Res"},{"key":"6_CR66","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045","journal-title":"Science"},{"key":"6_CR67","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/0148607111434963","volume":"36","author":"J-C Preiser","year":"2012","unstructured":"Preiser J-C (2012) Oxidative stress. JPEN J Parenter Enteral Nutr 36:147\u2013154. https:\/\/doi.org\/10.1177\/0148607111434963","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"6_CR68","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1128\/JVI.00485-10","volume":"84","author":"M Raaben","year":"2010","unstructured":"Raaben M, Posthuma CC, Verheije MH et al (2010) The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle. J Virol 84:7869\u20137879. https:\/\/doi.org\/10.1128\/JVI.00485-10","journal-title":"J Virol"},{"key":"6_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2020.100765","volume":"20","author":"MJ Ramaiah","year":"2020","unstructured":"Ramaiah MJ (2020) MTOR inhibition and p53 activation, microRNAs: the possible therapy against pandemic COVID-19. Gene Rep 20:100765. https:\/\/doi.org\/10.1016\/j.genrep.2020.100765","journal-title":"Gene Rep"},{"key":"6_CR70","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","volume":"15","author":"AV Raveendran","year":"2021","unstructured":"Raveendran AV, Jayadevan R, Sashidharan S (2021) Long COVID: an overview. Diabetes Metab Syndr 15:869\u2013875. https:\/\/doi.org\/10.1016\/j.dsx.2021.04.007","journal-title":"Diabetes Metab Syndr"},{"key":"6_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.621735","volume":"11","author":"EE Reza-Zald\u00edvar","year":"2021","unstructured":"Reza-Zald\u00edvar EE, Hern\u00e1ndez-Sapi\u00e9ns MA, Minjarez B et al (2021) Infection mechanism of SARS-COV-2 and its implication on the nervous system. Front Immunol 11:621735. https:\/\/doi.org\/10.3389\/fimmu.2020.621735","journal-title":"Front Immunol"},{"key":"6_CR72","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1212\/WNL.0000000000009937","volume":"95","author":"CM Romero-S\u00e1nchez","year":"2020","unstructured":"Romero-S\u00e1nchez CM, D\u00edaz-Maroto I, Fern\u00e1ndez-D\u00edaz E et al (2020) Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology 95:e1060\u2013e1070. https:\/\/doi.org\/10.1212\/WNL.0000000000009937","journal-title":"Neurology"},{"key":"6_CR73","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fnmol.2016.00157","volume":"9","author":"G Sala","year":"2016","unstructured":"Sala G, Marinig D, Arosio A, Ferrarese C (2016) Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson\u2019s disease. Front Mol Neurosci 9:157. https:\/\/doi.org\/10.3389\/fnmol.2016.00157","journal-title":"Front Mol Neurosci"},{"key":"6_CR74","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/febs.13249","volume":"282","author":"M Seirafi","year":"2015","unstructured":"Seirafi M, Kozlov G, Gehring K (2015) Parkin structure and function. FEBS J 282:2076\u20132088. https:\/\/doi.org\/10.1111\/febs.13249","journal-title":"FEBS J"},{"key":"6_CR75","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1021\/acschemneuro.1c00666","volume":"13","author":"SA Semerdzhiev","year":"2022","unstructured":"Semerdzhiev SA, Fakhree MAA, Segers-Nolten I et al (2022) Interactions between SARS-CoV-2 N-Protein and \u03b1-Synuclein accelerate amyloid formation. ACS Chem Neurosci 13:143\u2013150. https:\/\/doi.org\/10.1021\/acschemneuro.1c00666","journal-title":"ACS Chem Neurosci"},{"key":"6_CR76","doi-asserted-by":"publisher","unstructured":"Seyoum Tola F (2023) The role of ubiquitin-proteasome system in the pathogenesis of severe acute respiratory syndrome coronavirus-2 disease. Int J Inflam 2023:6698069. https:\/\/doi.org\/10.1155\/2023\/6698069","DOI":"10.1155\/2023\/6698069"},{"key":"6_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.780768","volume":"12","author":"C Shang","year":"2021","unstructured":"Shang C, Liu Z, Zhu Y et al (2021) SARS-CoV-2 causes mitochondrial dysfunction and mitophagy impairment. Front Microbiol 12:780768. https:\/\/doi.org\/10.3389\/fmicb.2021.780768","journal-title":"Front Microbiol"},{"key":"6_CR78","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.1038\/s41467-022-34065-3","volume":"13","author":"W-J Shin","year":"2022","unstructured":"Shin W-J, Ha DP, Machida K, Lee AS (2022) The stress-inducible ER chaperone GRP78\/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein. Nat Commun 13:6551. https:\/\/doi.org\/10.1038\/s41467-022-34065-3","journal-title":"Nat Commun"},{"key":"6_CR79","doi-asserted-by":"publisher","unstructured":"Sinha S, Mittal S, Roy R (2021) Parkinson\u2019s disease and the COVID-19 pandemic: a review article on the association between SARS-CoV-2 and \u03b1-Synucleinopathy. JMD 14:184\u2013192. https:\/\/doi.org\/10.14802\/jmd.21046","DOI":"10.14802\/jmd.21046"},{"key":"6_CR80","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3390\/biom12070971","volume":"12","author":"A Sodagar","year":"2022","unstructured":"Sodagar A, Javed R, Tahir H et al (2022) Pathological features and neuroinflammatory mechanisms of SARS-CoV-2 in the brain and potential therapeutic approaches. Biomolecules 12:971. https:\/\/doi.org\/10.3390\/biom12070971","journal-title":"Biomolecules"},{"key":"6_CR81","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202135","volume":"218","author":"E Song","year":"2021","unstructured":"Song E, Zhang C, Israelow B et al (2021) Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 218:e20202135. https:\/\/doi.org\/10.1084\/jem.20202135","journal-title":"J Exp Med"},{"key":"6_CR82","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1093\/brain\/awac270","volume":"145","author":"AL Soung","year":"2022","unstructured":"Soung AL, Vanderheiden A, Nordvig AS et al (2022) COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain 145:4193\u20134201. https:\/\/doi.org\/10.1093\/brain\/awac270","journal-title":"Brain"},{"key":"6_CR83","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/biomedicines11020498","volume":"11","author":"Y Stroylova","year":"2023","unstructured":"Stroylova Y, Konstantinova A, Stroylov V et al (2023) Does the SARS-CoV-2 spike receptor-binding domain hamper the amyloid transformation of Alpha-Synuclein after all? Biomedicines 11:498. https:\/\/doi.org\/10.3390\/biomedicines11020498","journal-title":"Biomedicines"},{"key":"6_CR84","doi-asserted-by":"publisher","unstructured":"Sulzer D, Antonini A, Leta V et al (2020) COVID-19 and possible links with Parkinson\u2019s disease and parkinsonism: from bench to bedside. NPJ Parkinsons Dis 6:18. https:\/\/doi.org\/10.1038\/s41531-020-00123-0","DOI":"10.1038\/s41531-020-00123-0"},{"key":"6_CR85","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jnc.14810","volume":"150","author":"D Sulzer","year":"2019","unstructured":"Sulzer D, Edwards RH (2019) The physiological role of \u03b1-synuclein and its relationship to Parkinson\u2019s Disease. J Neurochem 150:475\u2013486. https:\/\/doi.org\/10.1111\/jnc.14810","journal-title":"J Neurochem"},{"key":"6_CR86","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1523\/JNEUROSCI.3188-20.2021","volume":"41","author":"O Swain","year":"2021","unstructured":"Swain O, Romano SK, Miryala R et al (2021) SARS-CoV-2 neuronal invasion and complications: potential mechanisms and therapeutic approaches. J Neurosci 41:5338\u20135349. https:\/\/doi.org\/10.1523\/JNEUROSCI.3188-20.2021","journal-title":"J Neurosci"},{"key":"6_CR87","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3389\/fphar.2020.00856","volume":"11","author":"G Terrazzano","year":"2020","unstructured":"Terrazzano G, Rubino V, Palatucci AT et al (2020) An open question: is it rational to inhibit the mTor-dependent pathway as COVID-19 therapy? Front Pharmacol 11:856. https:\/\/doi.org\/10.3389\/fphar.2020.00856","journal-title":"Front Pharmacol"},{"key":"6_CR88","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.stemcr.2021.02.005","volume":"16","author":"SK Tiwari","year":"2021","unstructured":"Tiwari SK, Wang S, Smith D et al (2021) Revealing tissue-specific SARS-CoV-2 infection and host responses using human stem cell-derived lung and cerebral organoids. Stem Cell Rep 16:437\u2013445. https:\/\/doi.org\/10.1016\/j.stemcr.2021.02.005","journal-title":"Stem Cell Rep"},{"key":"6_CR89","doi-asserted-by":"publisher","first-page":"44405","DOI":"10.1074\/jbc.M308041200","volume":"278","author":"GK Tofaris","year":"2003","unstructured":"Tofaris GK, Razzaq A, Ghetti B et al (2003) Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem 278:44405\u201344411. https:\/\/doi.org\/10.1074\/jbc.M308041200","journal-title":"J Biol Chem"},{"key":"6_CR90","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/jnc.15154","volume":"156","author":"D Trinh","year":"2021","unstructured":"Trinh D, Israwi AR, Arathoon LR et al (2021) The multi-faceted role of mitochondria in the pathology of Parkinson\u2019s disease. J Neurochem 156:715\u2013752. https:\/\/doi.org\/10.1111\/jnc.15154","journal-title":"J Neurochem"},{"key":"6_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.899198","volume":"13","author":"C Vollbracht","year":"2022","unstructured":"Vollbracht C, Kraft K (2022) Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous Vitamin C. Front Pharmacol 13:899198. https:\/\/doi.org\/10.3389\/fphar.2022.899198","journal-title":"Front Pharmacol"},{"key":"6_CR92","doi-asserted-by":"crossref","unstructured":"Weissmann G, Dukor P (1970) The role of lysosomes in immune responses. In: Advances in immunology. Elsevier, Amsterdam, pp 283\u2013331","DOI":"10.1016\/S0065-2776(08)60172-8"},{"key":"6_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D (2017) \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med 23:1\u201313. https:\/\/doi.org\/10.1038\/nm.4269","journal-title":"Nat Med"},{"key":"6_CR94","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.3390\/ijms23063394","volume":"23","author":"Z Wu","year":"2022","unstructured":"Wu Z, Zhang X, Huang Z, Ma K (2022) SARS-CoV-2 Proteins interact with Alpha Synuclein and induce Lewy body-like pathology in vitro. Int J Mol Sci 23:3394. https:\/\/doi.org\/10.3390\/ijms23063394","journal-title":"Int J Mol Sci"},{"key":"6_CR95","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1172\/JCI37617","volume":"119","author":"H Xiong","year":"2009","unstructured":"Xiong H, Wang D, Chen L et al (2009) Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest 119:650\u2013660. https:\/\/doi.org\/10.1172\/JCI37617","journal-title":"J Clin Invest"},{"key":"6_CR96","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.3390\/ijms24076338","volume":"24","author":"V Yahya","year":"2023","unstructured":"Yahya V, Di Fonzo A, Monfrini E (2023) Genetic evidence for endolysosomal dysfunction in Parkinson\u2019s disease: a critical overview. IJMS 24:6338. https:\/\/doi.org\/10.3390\/ijms24076338","journal-title":"IJMS"},{"key":"6_CR97","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","volume":"27","author":"L Yang","year":"2020","unstructured":"Yang L, Han Y, Nilsson-Payant BE et al (2020) A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell 27:125-136.e7. https:\/\/doi.org\/10.1016\/j.stem.2020.06.015","journal-title":"Cell Stem Cell"},{"key":"6_CR98","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3390\/nu12051466","volume":"12","author":"I Zabetakis","year":"2020","unstructured":"Zabetakis I, Lordan R, Norton C, Tsoupras A (2020) COVID-19: The inflammation link and the role of nutrition in potential mitigation. Nutrients 12:1466. https:\/\/doi.org\/10.3390\/nu12051466","journal-title":"Nutrients"},{"key":"6_CR99","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-021-00268-z","volume":"7","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Sun H, Pei R et al (2021) The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes. Cell Discov 7:31. https:\/\/doi.org\/10.1038\/s41421-021-00268-z","journal-title":"Cell Discov"},{"key":"6_CR100","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2065","volume":"77","author":"AS Zubair","year":"2020","unstructured":"Zubair AS, McAlpine LS, Gardin T et al (2020) Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a Review. JAMA Neurol 77:1018. https:\/\/doi.org\/10.1001\/jamaneurol.2020.2065","journal-title":"JAMA Neurol"}],"container-title":["Advances in Experimental Medicine and Biology","The COVID-19 Aftermath"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-61939-7_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:04:44Z","timestamp":1726484684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-61939-7_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031619380","9783031619397"],"references-count":100,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-61939-7_6","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"17 September 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}